nodes	percent_of_prediction	percent_of_DWPC	metapath
Norethindrone—CYP2C19—Memantine—Alzheimer's disease	0.203	0.383	CbGbCtD
Norethindrone—CYP3A4—Rivastigmine—Alzheimer's disease	0.142	0.267	CbGbCtD
Norethindrone—CYP3A4—Donepezil—Alzheimer's disease	0.113	0.213	CbGbCtD
Norethindrone—CYP3A4—Galantamine—Alzheimer's disease	0.0731	0.137	CbGbCtD
Norethindrone—Carcinoma—Rivastigmine—Alzheimer's disease	0.0103	0.0319	CcSEcCtD
Norethindrone—Abdominal bloating—Donepezil—Alzheimer's disease	0.00734	0.0228	CcSEcCtD
Norethindrone—Cerebral haemorrhage—Donepezil—Alzheimer's disease	0.00631	0.0196	CcSEcCtD
Norethindrone—Hirsutism—Donepezil—Alzheimer's disease	0.00601	0.0186	CcSEcCtD
Norethindrone—Deep vein thrombosis—Donepezil—Alzheimer's disease	0.00574	0.0178	CcSEcCtD
Norethindrone—Cerebral haemorrhage—Memantine—Alzheimer's disease	0.00573	0.0178	CcSEcCtD
Norethindrone—Deep vein thrombosis—Memantine—Alzheimer's disease	0.00521	0.0162	CcSEcCtD
Norethindrone—Embolism—Memantine—Alzheimer's disease	0.00494	0.0153	CcSEcCtD
Norethindrone—Metrorrhagia—Donepezil—Alzheimer's disease	0.00489	0.0152	CcSEcCtD
Norethindrone—Thrombosis—Rivastigmine—Alzheimer's disease	0.00438	0.0136	CcSEcCtD
Norethindrone—Metrorrhagia—Rivastigmine—Alzheimer's disease	0.00434	0.0135	CcSEcCtD
Norethindrone—Vaginal haemorrhage—Memantine—Alzheimer's disease	0.00429	0.0133	CcSEcCtD
Norethindrone—Dermatitis atopic—Rivastigmine—Alzheimer's disease	0.00419	0.013	CcSEcCtD
Norethindrone—Vaginal haemorrhage—Rivastigmine—Alzheimer's disease	0.00419	0.013	CcSEcCtD
Norethindrone—Neoplasm malignant—Rivastigmine—Alzheimer's disease	0.00363	0.0113	CcSEcCtD
Norethindrone—Breast pain—Rivastigmine—Alzheimer's disease	0.00356	0.011	CcSEcCtD
Norethindrone—Renal impairment—Galantamine—Alzheimer's disease	0.00344	0.0107	CcSEcCtD
Norethindrone—Purpura—Galantamine—Alzheimer's disease	0.0034	0.0105	CcSEcCtD
Norethindrone—Pain in extremity—Galantamine—Alzheimer's disease	0.00327	0.0101	CcSEcCtD
Norethindrone—Pulmonary embolism—Memantine—Alzheimer's disease	0.00317	0.00984	CcSEcCtD
Norethindrone—Pulmonary embolism—Rivastigmine—Alzheimer's disease	0.0031	0.00962	CcSEcCtD
Norethindrone—Thrombophlebitis—Memantine—Alzheimer's disease	0.00266	0.00825	CcSEcCtD
Norethindrone—Thrombophlebitis—Rivastigmine—Alzheimer's disease	0.0026	0.00807	CcSEcCtD
Norethindrone—Depression—Galantamine—Alzheimer's disease	0.00251	0.0078	CcSEcCtD
Norethindrone—Affect lability—Donepezil—Alzheimer's disease	0.0025	0.00774	CcSEcCtD
Norethindrone—Renal failure—Galantamine—Alzheimer's disease	0.00248	0.00769	CcSEcCtD
Norethindrone—Renal impairment—Memantine—Alzheimer's disease	0.00242	0.0075	CcSEcCtD
Norethindrone—Mood swings—Donepezil—Alzheimer's disease	0.0024	0.00745	CcSEcCtD
Norethindrone—Purpura—Memantine—Alzheimer's disease	0.00239	0.00741	CcSEcCtD
Norethindrone—Hepatobiliary disease—Galantamine—Alzheimer's disease	0.00239	0.0074	CcSEcCtD
Norethindrone—Renal impairment—Rivastigmine—Alzheimer's disease	0.00237	0.00734	CcSEcCtD
Norethindrone—Purpura—Rivastigmine—Alzheimer's disease	0.00234	0.00725	CcSEcCtD
Norethindrone—Pain in extremity—Memantine—Alzheimer's disease	0.0023	0.00714	CcSEcCtD
Norethindrone—Haemoglobin—Galantamine—Alzheimer's disease	0.00228	0.00706	CcSEcCtD
Norethindrone—Affect lability—Memantine—Alzheimer's disease	0.00227	0.00703	CcSEcCtD
Norethindrone—Hepatitis—Galantamine—Alzheimer's disease	0.00226	0.00702	CcSEcCtD
Norethindrone—Haemorrhage—Galantamine—Alzheimer's disease	0.00226	0.00702	CcSEcCtD
Norethindrone—Pain in extremity—Rivastigmine—Alzheimer's disease	0.00225	0.00699	CcSEcCtD
Norethindrone—Connective tissue disorder—Galantamine—Alzheimer's disease	0.00222	0.0069	CcSEcCtD
Norethindrone—Migraine—Rivastigmine—Alzheimer's disease	0.00222	0.00688	CcSEcCtD
Norethindrone—Affect lability—Rivastigmine—Alzheimer's disease	0.00222	0.00688	CcSEcCtD
Norethindrone—Abdominal distension—Donepezil—Alzheimer's disease	0.00221	0.00684	CcSEcCtD
Norethindrone—Mood swings—Memantine—Alzheimer's disease	0.00218	0.00676	CcSEcCtD
Norethindrone—Mood swings—Rivastigmine—Alzheimer's disease	0.00213	0.00662	CcSEcCtD
Norethindrone—Immune system disorder—Galantamine—Alzheimer's disease	0.00204	0.00634	CcSEcCtD
Norethindrone—Breast disorder—Rivastigmine—Alzheimer's disease	0.00204	0.00631	CcSEcCtD
Norethindrone—Weight increased—Donepezil—Alzheimer's disease	0.00199	0.00619	CcSEcCtD
Norethindrone—Mental disorder—Galantamine—Alzheimer's disease	0.00198	0.00615	CcSEcCtD
Norethindrone—Depression—Donepezil—Alzheimer's disease	0.00195	0.00604	CcSEcCtD
Norethindrone—Flatulence—Galantamine—Alzheimer's disease	0.00194	0.00602	CcSEcCtD
Norethindrone—Tension—Galantamine—Alzheimer's disease	0.00193	0.006	CcSEcCtD
Norethindrone—Acute coronary syndrome—Donepezil—Alzheimer's disease	0.00193	0.00597	CcSEcCtD
Norethindrone—Renal failure—Donepezil—Alzheimer's disease	0.00192	0.00596	CcSEcCtD
Norethindrone—Myocardial infarction—Donepezil—Alzheimer's disease	0.00192	0.00594	CcSEcCtD
Norethindrone—Nervousness—Galantamine—Alzheimer's disease	0.00191	0.00594	CcSEcCtD
Norethindrone—Weight increased—Memantine—Alzheimer's disease	0.00181	0.00562	CcSEcCtD
Norethindrone—Photosensitivity reaction—Rivastigmine—Alzheimer's disease	0.00178	0.00551	CcSEcCtD
Norethindrone—Weight increased—Rivastigmine—Alzheimer's disease	0.00177	0.00549	CcSEcCtD
Norethindrone—Depression—Memantine—Alzheimer's disease	0.00177	0.00549	CcSEcCtD
Norethindrone—Haemoglobin—Donepezil—Alzheimer's disease	0.00176	0.00547	CcSEcCtD
Norethindrone—Hepatitis—Donepezil—Alzheimer's disease	0.00175	0.00544	CcSEcCtD
Norethindrone—Haemorrhage—Donepezil—Alzheimer's disease	0.00175	0.00544	CcSEcCtD
Norethindrone—Acute coronary syndrome—Memantine—Alzheimer's disease	0.00175	0.00542	CcSEcCtD
Norethindrone—Renal failure—Memantine—Alzheimer's disease	0.00174	0.00541	CcSEcCtD
Norethindrone—Myocardial infarction—Memantine—Alzheimer's disease	0.00174	0.00539	CcSEcCtD
Norethindrone—Drowsiness—Rivastigmine—Alzheimer's disease	0.00174	0.00538	CcSEcCtD
Norethindrone—Depression—Rivastigmine—Alzheimer's disease	0.00173	0.00537	CcSEcCtD
Norethindrone—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.00171	0.00531	CcSEcCtD
Norethindrone—Convulsion—Galantamine—Alzheimer's disease	0.00171	0.00529	CcSEcCtD
Norethindrone—Renal failure—Rivastigmine—Alzheimer's disease	0.00171	0.00529	CcSEcCtD
Norethindrone—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.0017	0.00528	CcSEcCtD
Norethindrone—Hepatobiliary disease—Memantine—Alzheimer's disease	0.00168	0.0052	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.00167	0.00517	CcSEcCtD
Norethindrone—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.00164	0.00509	CcSEcCtD
Norethindrone—Nandrolone decanoate—MAOB—Alzheimer's disease	0.00164	0.116	CrCbGaD
Norethindrone—Haemoglobin—Memantine—Alzheimer's disease	0.0016	0.00496	CcSEcCtD
Norethindrone—Hepatitis—Memantine—Alzheimer's disease	0.00159	0.00494	CcSEcCtD
Norethindrone—Haemorrhage—Memantine—Alzheimer's disease	0.00159	0.00494	CcSEcCtD
Norethindrone—Haemoglobin—Rivastigmine—Alzheimer's disease	0.00157	0.00486	CcSEcCtD
Norethindrone—Connective tissue disorder—Memantine—Alzheimer's disease	0.00157	0.00485	CcSEcCtD
Norethindrone—Skin disorder—Galantamine—Alzheimer's disease	0.00156	0.00484	CcSEcCtD
Norethindrone—Hepatitis—Rivastigmine—Alzheimer's disease	0.00156	0.00483	CcSEcCtD
Norethindrone—Haemorrhage—Rivastigmine—Alzheimer's disease	0.00156	0.00483	CcSEcCtD
Norethindrone—Alopecia—Donepezil—Alzheimer's disease	0.00155	0.00481	CcSEcCtD
Norethindrone—Mental disorder—Donepezil—Alzheimer's disease	0.00154	0.00477	CcSEcCtD
Norethindrone—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.00153	0.00475	CcSEcCtD
Norethindrone—Erythema multiforme—Memantine—Alzheimer's disease	0.00151	0.00467	CcSEcCtD
Norethindrone—Flatulence—Donepezil—Alzheimer's disease	0.00151	0.00467	CcSEcCtD
Norethindrone—Tension—Donepezil—Alzheimer's disease	0.0015	0.00465	CcSEcCtD
Norethindrone—Nervousness—Donepezil—Alzheimer's disease	0.00148	0.0046	CcSEcCtD
Norethindrone—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.00147	0.00457	CcSEcCtD
Norethindrone—Insomnia—Galantamine—Alzheimer's disease	0.00145	0.00451	CcSEcCtD
Norethindrone—Immune system disorder—Memantine—Alzheimer's disease	0.00144	0.00446	CcSEcCtD
Norethindrone—Somnolence—Galantamine—Alzheimer's disease	0.00143	0.00443	CcSEcCtD
Norethindrone—Dyspepsia—Galantamine—Alzheimer's disease	0.00142	0.00439	CcSEcCtD
Norethindrone—Alopecia—Memantine—Alzheimer's disease	0.00141	0.00437	CcSEcCtD
Norethindrone—Mental disorder—Memantine—Alzheimer's disease	0.0014	0.00433	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.00139	0.00431	CcSEcCtD
Norethindrone—Fatigue—Galantamine—Alzheimer's disease	0.00139	0.0043	CcSEcCtD
Norethindrone—Danazol—CCL2—Alzheimer's disease	0.00138	0.0978	CrCbGaD
Norethindrone—Alopecia—Rivastigmine—Alzheimer's disease	0.00138	0.00427	CcSEcCtD
Norethindrone—Flatulence—Memantine—Alzheimer's disease	0.00137	0.00424	CcSEcCtD
Norethindrone—Mental disorder—Rivastigmine—Alzheimer's disease	0.00137	0.00423	CcSEcCtD
Norethindrone—Tension—Memantine—Alzheimer's disease	0.00136	0.00422	CcSEcCtD
Norethindrone—Quinestrol—ESR1—Alzheimer's disease	0.00136	0.0963	CrCbGaD
Norethindrone—Nervousness—Memantine—Alzheimer's disease	0.00135	0.00418	CcSEcCtD
Norethindrone—Flatulence—Rivastigmine—Alzheimer's disease	0.00134	0.00415	CcSEcCtD
Norethindrone—Tension—Rivastigmine—Alzheimer's disease	0.00133	0.00413	CcSEcCtD
Norethindrone—Convulsion—Donepezil—Alzheimer's disease	0.00132	0.0041	CcSEcCtD
Norethindrone—Nervousness—Rivastigmine—Alzheimer's disease	0.00132	0.00409	CcSEcCtD
Norethindrone—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.00132	0.00408	CcSEcCtD
Norethindrone—Abdominal pain—Galantamine—Alzheimer's disease	0.00127	0.00394	CcSEcCtD
Norethindrone—Oedema—Donepezil—Alzheimer's disease	0.00125	0.00387	CcSEcCtD
Norethindrone—Convulsion—Memantine—Alzheimer's disease	0.0012	0.00373	CcSEcCtD
Norethindrone—Hypersensitivity—Galantamine—Alzheimer's disease	0.00119	0.00367	CcSEcCtD
Norethindrone—Convulsion—Rivastigmine—Alzheimer's disease	0.00118	0.00364	CcSEcCtD
Norethindrone—Asthenia—Galantamine—Alzheimer's disease	0.00115	0.00358	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.00115	0.00356	CcSEcCtD
Norethindrone—Oedema—Memantine—Alzheimer's disease	0.00113	0.00351	CcSEcCtD
Norethindrone—Insomnia—Donepezil—Alzheimer's disease	0.00113	0.0035	CcSEcCtD
Norethindrone—Ethynodiol—ESR1—Alzheimer's disease	0.00112	0.0793	CrCbGaD
Norethindrone—Somnolence—Donepezil—Alzheimer's disease	0.00111	0.00344	CcSEcCtD
Norethindrone—Oedema—Rivastigmine—Alzheimer's disease	0.00111	0.00343	CcSEcCtD
Norethindrone—Skin disorder—Memantine—Alzheimer's disease	0.0011	0.00341	CcSEcCtD
Norethindrone—Dyspepsia—Donepezil—Alzheimer's disease	0.0011	0.0034	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.00108	0.00334	CcSEcCtD
Norethindrone—Skin disorder—Rivastigmine—Alzheimer's disease	0.00108	0.00333	CcSEcCtD
Norethindrone—Fatigue—Donepezil—Alzheimer's disease	0.00107	0.00333	CcSEcCtD
Norethindrone—Dizziness—Galantamine—Alzheimer's disease	0.00106	0.0033	CcSEcCtD
Norethindrone—Allylestrenol—ESR1—Alzheimer's disease	0.00106	0.0749	CrCbGaD
Norethindrone—Mestranol—ESR1—Alzheimer's disease	0.00103	0.073	CrCbGaD
Norethindrone—Insomnia—Memantine—Alzheimer's disease	0.00102	0.00317	CcSEcCtD
Norethindrone—Vomiting—Galantamine—Alzheimer's disease	0.00102	0.00317	CcSEcCtD
Norethindrone—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.00102	0.00316	CcSEcCtD
Norethindrone—Desogestrel—ESR1—Alzheimer's disease	0.00102	0.0721	CrCbGaD
Norethindrone—Rash—Galantamine—Alzheimer's disease	0.00101	0.00314	CcSEcCtD
Norethindrone—Dermatitis—Galantamine—Alzheimer's disease	0.00101	0.00314	CcSEcCtD
Norethindrone—Headache—Galantamine—Alzheimer's disease	0.00101	0.00312	CcSEcCtD
Norethindrone—Somnolence—Memantine—Alzheimer's disease	0.00101	0.00312	CcSEcCtD
Norethindrone—Insomnia—Rivastigmine—Alzheimer's disease	0.001	0.00311	CcSEcCtD
Norethindrone—Dyspepsia—Memantine—Alzheimer's disease	0.000996	0.00309	CcSEcCtD
Norethindrone—Urticaria—Donepezil—Alzheimer's disease	0.00099	0.00307	CcSEcCtD
Norethindrone—Abdominal pain—Donepezil—Alzheimer's disease	0.000985	0.00306	CcSEcCtD
Norethindrone—Somnolence—Rivastigmine—Alzheimer's disease	0.000984	0.00305	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000977	0.00303	CcSEcCtD
Norethindrone—Fatigue—Memantine—Alzheimer's disease	0.000976	0.00303	CcSEcCtD
Norethindrone—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000975	0.00302	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000956	0.00296	CcSEcCtD
Norethindrone—Nausea—Galantamine—Alzheimer's disease	0.000955	0.00296	CcSEcCtD
Norethindrone—Fatigue—Rivastigmine—Alzheimer's disease	0.000955	0.00296	CcSEcCtD
Norethindrone—Norgestimate—ESR1—Alzheimer's disease	0.00095	0.0675	CrCbGaD
Norethindrone—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000926	0.00287	CcSEcCtD
Norethindrone—Hypersensitivity—Donepezil—Alzheimer's disease	0.000918	0.00285	CcSEcCtD
Norethindrone—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000905	0.00281	CcSEcCtD
Norethindrone—Urticaria—Memantine—Alzheimer's disease	0.000899	0.00279	CcSEcCtD
Norethindrone—Abdominal pain—Memantine—Alzheimer's disease	0.000895	0.00277	CcSEcCtD
Norethindrone—Asthenia—Donepezil—Alzheimer's disease	0.000894	0.00277	CcSEcCtD
Norethindrone—Pruritus—Donepezil—Alzheimer's disease	0.000882	0.00273	CcSEcCtD
Norethindrone—Urticaria—Rivastigmine—Alzheimer's disease	0.00088	0.00273	CcSEcCtD
Norethindrone—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000875	0.00271	CcSEcCtD
Norethindrone—Hypersensitivity—Memantine—Alzheimer's disease	0.000834	0.00259	CcSEcCtD
Norethindrone—Dizziness—Donepezil—Alzheimer's disease	0.000824	0.00256	CcSEcCtD
Norethindrone—Etonogestrel—ESR1—Alzheimer's disease	0.000822	0.0584	CrCbGaD
Norethindrone—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000816	0.00253	CcSEcCtD
Norethindrone—Asthenia—Memantine—Alzheimer's disease	0.000812	0.00252	CcSEcCtD
Norethindrone—Pruritus—Memantine—Alzheimer's disease	0.000801	0.00248	CcSEcCtD
Norethindrone—Asthenia—Rivastigmine—Alzheimer's disease	0.000794	0.00246	CcSEcCtD
Norethindrone—Vomiting—Donepezil—Alzheimer's disease	0.000793	0.00246	CcSEcCtD
Norethindrone—Rash—Donepezil—Alzheimer's disease	0.000786	0.00244	CcSEcCtD
Norethindrone—Dermatitis—Donepezil—Alzheimer's disease	0.000785	0.00243	CcSEcCtD
Norethindrone—Pruritus—Rivastigmine—Alzheimer's disease	0.000783	0.00243	CcSEcCtD
Norethindrone—Headache—Donepezil—Alzheimer's disease	0.000781	0.00242	CcSEcCtD
Norethindrone—Drospirenone—BCHE—Alzheimer's disease	0.000773	0.0549	CrCbGaD
Norethindrone—Dizziness—Memantine—Alzheimer's disease	0.000748	0.00232	CcSEcCtD
Norethindrone—Nausea—Donepezil—Alzheimer's disease	0.00074	0.0023	CcSEcCtD
Norethindrone—Dizziness—Rivastigmine—Alzheimer's disease	0.000732	0.00227	CcSEcCtD
Norethindrone—Vomiting—Memantine—Alzheimer's disease	0.00072	0.00223	CcSEcCtD
Norethindrone—Rash—Memantine—Alzheimer's disease	0.000714	0.00221	CcSEcCtD
Norethindrone—Dermatitis—Memantine—Alzheimer's disease	0.000713	0.00221	CcSEcCtD
Norethindrone—Headache—Memantine—Alzheimer's disease	0.000709	0.0022	CcSEcCtD
Norethindrone—Vomiting—Rivastigmine—Alzheimer's disease	0.000704	0.00218	CcSEcCtD
Norethindrone—Rash—Rivastigmine—Alzheimer's disease	0.000698	0.00216	CcSEcCtD
Norethindrone—Dermatitis—Rivastigmine—Alzheimer's disease	0.000697	0.00216	CcSEcCtD
Norethindrone—Headache—Rivastigmine—Alzheimer's disease	0.000694	0.00215	CcSEcCtD
Norethindrone—Nausea—Memantine—Alzheimer's disease	0.000672	0.00208	CcSEcCtD
Norethindrone—Nausea—Rivastigmine—Alzheimer's disease	0.000658	0.00204	CcSEcCtD
Norethindrone—Levonorgestrel—ESR1—Alzheimer's disease	0.000582	0.0413	CrCbGaD
Norethindrone—Fluoxymesterone—ESR1—Alzheimer's disease	0.000554	0.0394	CrCbGaD
Norethindrone—Danazol—ESR1—Alzheimer's disease	0.00053	0.0376	CrCbGaD
Norethindrone—Ethinyl Estradiol—ESR1—Alzheimer's disease	0.00049	0.0348	CrCbGaD
Norethindrone—Drospirenone—PTGS2—Alzheimer's disease	0.000356	0.0253	CrCbGaD
Norethindrone—Progesterone—ESR1—Alzheimer's disease	0.000275	0.0195	CrCbGaD
Norethindrone—Progesterone—CYP2D6—Alzheimer's disease	0.000163	0.0116	CrCbGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	5.62e-05	0.000426	CbGpPWpGaD
Norethindrone—ALB—Metabolism—ND1—Alzheimer's disease	5.58e-05	0.000423	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	5.55e-05	0.000421	CbGpPWpGaD
Norethindrone—ABCB1—HIF-1-alpha transcription factor network—AKT1—Alzheimer's disease	5.55e-05	0.00042	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—MAOB—Alzheimer's disease	5.54e-05	0.00042	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PLD3—Alzheimer's disease	5.48e-05	0.000416	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	5.45e-05	0.000413	CbGpPWpGaD
Norethindrone—ALB—Selenium Micronutrient Network—IL6—Alzheimer's disease	5.45e-05	0.000413	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—PLCB1—Alzheimer's disease	5.41e-05	0.00041	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—HSD17B10—Alzheimer's disease	5.39e-05	0.000408	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—GAPDH—Alzheimer's disease	5.33e-05	0.000404	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	5.27e-05	0.000399	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—HSD17B10—Alzheimer's disease	5.26e-05	0.000399	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CYP46A1—Alzheimer's disease	5.19e-05	0.000393	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—A2M—Alzheimer's disease	5.15e-05	0.00039	CbGpPWpGaD
Norethindrone—ABCB1—Transmembrane transport of small molecules—TF—Alzheimer's disease	5.1e-05	0.000386	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CYP46A1—Alzheimer's disease	5.06e-05	0.000384	CbGpPWpGaD
Norethindrone—PGR—Gene Expression—ESR1—Alzheimer's disease	5.06e-05	0.000384	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—NGFR—Alzheimer's disease	5.04e-05	0.000382	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—ND1—Alzheimer's disease	5.01e-05	0.00038	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	4.99e-05	0.000378	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—Alzheimer's disease	4.96e-05	0.000376	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—ADAM10—Alzheimer's disease	4.93e-05	0.000373	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	4.9e-05	0.000371	CbGpPWpGaD
Norethindrone—PGR—Gene Expression—NOTCH1—Alzheimer's disease	4.89e-05	0.000371	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—ND1—Alzheimer's disease	4.89e-05	0.000371	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—SOD1—Alzheimer's disease	4.88e-05	0.00037	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Alzheimer's disease	4.72e-05	0.000358	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	4.67e-05	0.000354	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—S100B—Alzheimer's disease	4.66e-05	0.000353	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—IGF2—Alzheimer's disease	4.64e-05	0.000352	CbGpPWpGaD
Norethindrone—PGR—Gene Expression—PPARG—Alzheimer's disease	4.62e-05	0.00035	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—ACHE—Alzheimer's disease	4.48e-05	0.000339	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	4.48e-05	0.000339	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—IGF2—Alzheimer's disease	4.44e-05	0.000336	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—INPP5D—Alzheimer's disease	4.43e-05	0.000336	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	4.38e-05	0.000332	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	4.3e-05	0.000326	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—IGF1R—Alzheimer's disease	4.29e-05	0.000325	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—ENO1—Alzheimer's disease	4.2e-05	0.000318	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PTGS1—Alzheimer's disease	4.2e-05	0.000318	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—PRKCG—Alzheimer's disease	4.18e-05	0.000317	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—TPI1—Alzheimer's disease	4.17e-05	0.000316	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—CHAT—Alzheimer's disease	4.17e-05	0.000316	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—CYP2D6—Alzheimer's disease	4.11e-05	0.000312	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—LPL—Alzheimer's disease	4.11e-05	0.000312	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—MEF2C—Alzheimer's disease	4.08e-05	0.000309	CbGpPWpGaD
Norethindrone—ALB—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	4.07e-05	0.000308	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	4.02e-05	0.000305	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—MAOB—Alzheimer's disease	4e-05	0.000303	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—PRKCG—Alzheimer's disease	4e-05	0.000303	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CA4—Alzheimer's disease	3.97e-05	0.000301	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	3.91e-05	0.000297	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—BCHE—Alzheimer's disease	3.9e-05	0.000296	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—NGF—Alzheimer's disease	3.89e-05	0.000295	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	3.86e-05	0.000293	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—GAPDH—Alzheimer's disease	3.85e-05	0.000292	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—CCR5—Alzheimer's disease	3.79e-05	0.000287	CbGpPWpGaD
Norethindrone—ALB—Platelet activation, signaling and aggregation—VEGFA—Alzheimer's disease	3.77e-05	0.000286	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	3.74e-05	0.000283	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—A2M—Alzheimer's disease	3.72e-05	0.000282	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	3.72e-05	0.000282	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—HTR2A—Alzheimer's disease	3.71e-05	0.000281	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PLCB1—Alzheimer's disease	3.68e-05	0.000279	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—PLAU—Alzheimer's disease	3.66e-05	0.000277	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—CALM1—Alzheimer's disease	3.62e-05	0.000274	CbGpPWpGaD
Norethindrone—ALB—Metabolism—TPI1—Alzheimer's disease	3.6e-05	0.000273	CbGpPWpGaD
Norethindrone—ALB—Metabolism—CHAT—Alzheimer's disease	3.6e-05	0.000273	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—CAV1—Alzheimer's disease	3.57e-05	0.000271	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—ABCA1—Alzheimer's disease	3.57e-05	0.00027	CbGpPWpGaD
Norethindrone—ABCB1—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	3.56e-05	0.00027	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	3.54e-05	0.000269	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	3.51e-05	0.000266	CbGpPWpGaD
Norethindrone—ALB—Platelet activation, signaling and aggregation—TGFB1—Alzheimer's disease	3.46e-05	0.000263	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—CALM1—Alzheimer's disease	3.46e-05	0.000262	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—LEP—Alzheimer's disease	3.45e-05	0.000261	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—APOE—Alzheimer's disease	3.45e-05	0.000261	CbGpPWpGaD
Norethindrone—ALB—Metabolism—MAOB—Alzheimer's disease	3.45e-05	0.000261	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—CAV1—Alzheimer's disease	3.42e-05	0.000259	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	3.41e-05	0.000258	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—F2—Alzheimer's disease	3.4e-05	0.000258	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PLD3—Alzheimer's disease	3.38e-05	0.000256	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—NOS2—Alzheimer's disease	3.36e-05	0.000255	CbGpPWpGaD
Norethindrone—ALB—Metabolism—GAPDH—Alzheimer's disease	3.32e-05	0.000252	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—ESR1—Alzheimer's disease	3.29e-05	0.000249	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	3.28e-05	0.000249	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—F2—Alzheimer's disease	3.25e-05	0.000246	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	3.25e-05	0.000246	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	3.24e-05	0.000246	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—ACHE—Alzheimer's disease	3.24e-05	0.000245	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CHAT—Alzheimer's disease	3.23e-05	0.000245	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—TPI1—Alzheimer's disease	3.23e-05	0.000245	CbGpPWpGaD
Norethindrone—ALB—Metabolism—A2M—Alzheimer's disease	3.2e-05	0.000243	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—INPP5D—Alzheimer's disease	3.2e-05	0.000243	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	3.18e-05	0.000241	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—NOTCH1—Alzheimer's disease	3.18e-05	0.000241	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CHAT—Alzheimer's disease	3.15e-05	0.000239	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—TPI1—Alzheimer's disease	3.15e-05	0.000239	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	3.12e-05	0.000236	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—MAOB—Alzheimer's disease	3.09e-05	0.000235	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PPARGC1A—Alzheimer's disease	3.08e-05	0.000233	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—HMOX1—Alzheimer's disease	3.06e-05	0.000232	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PTGS1—Alzheimer's disease	3.03e-05	0.00023	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—ENO1—Alzheimer's disease	3.03e-05	0.00023	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—MAOB—Alzheimer's disease	3.02e-05	0.000229	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ND1—Alzheimer's disease	3.01e-05	0.000228	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—GSK3B—Alzheimer's disease	2.99e-05	0.000226	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GAPDH—Alzheimer's disease	2.98e-05	0.000226	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—IGF1—Alzheimer's disease	2.98e-05	0.000226	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—CYP2D6—Alzheimer's disease	2.97e-05	0.000225	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—CREB1—Alzheimer's disease	2.96e-05	0.000224	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	2.94e-05	0.000223	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—INS—Alzheimer's disease	2.94e-05	0.000223	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	2.92e-05	0.000221	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GAPDH—Alzheimer's disease	2.91e-05	0.00022	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—CCL2—Alzheimer's disease	2.9e-05	0.00022	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—A2M—Alzheimer's disease	2.88e-05	0.000218	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	2.86e-05	0.000217	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—IGF1—Alzheimer's disease	2.85e-05	0.000216	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—BCHE—Alzheimer's disease	2.82e-05	0.000214	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—A2M—Alzheimer's disease	2.81e-05	0.000213	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	2.81e-05	0.000213	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—LPL—Alzheimer's disease	2.8e-05	0.000212	CbGpPWpGaD
Norethindrone—ALB—Metabolism—ACHE—Alzheimer's disease	2.79e-05	0.000211	CbGpPWpGaD
Norethindrone—ALB—Metabolism—INPP5D—Alzheimer's disease	2.76e-05	0.000209	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—NOS3—Alzheimer's disease	2.7e-05	0.000205	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PLCB1—Alzheimer's disease	2.66e-05	0.000202	CbGpPWpGaD
Norethindrone—ALB—Metabolism—ENO1—Alzheimer's disease	2.61e-05	0.000198	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PTGS1—Alzheimer's disease	2.61e-05	0.000198	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—NOS3—Alzheimer's disease	2.58e-05	0.000196	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—ABCA1—Alzheimer's disease	2.58e-05	0.000196	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	2.56e-05	0.000194	CbGpPWpGaD
Norethindrone—ALB—Metabolism—CYP2D6—Alzheimer's disease	2.56e-05	0.000194	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—MTHFR—Alzheimer's disease	2.52e-05	0.000191	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—ACHE—Alzheimer's disease	2.5e-05	0.00019	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—INPP5D—Alzheimer's disease	2.47e-05	0.000188	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—ACHE—Alzheimer's disease	2.44e-05	0.000185	CbGpPWpGaD
Norethindrone—ALB—Metabolism—BCHE—Alzheimer's disease	2.43e-05	0.000184	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—INPP5D—Alzheimer's disease	2.41e-05	0.000183	CbGpPWpGaD
Norethindrone—ALB—Platelet activation, signaling and aggregation—AKT1—Alzheimer's disease	2.41e-05	0.000182	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	2.37e-05	0.00018	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—CALM1—Alzheimer's disease	2.35e-05	0.000179	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—APOE—Alzheimer's disease	2.35e-05	0.000178	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—ENO1—Alzheimer's disease	2.34e-05	0.000178	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PTGS1—Alzheimer's disease	2.34e-05	0.000178	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—CAV1—Alzheimer's disease	2.33e-05	0.000176	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CYP2D6—Alzheimer's disease	2.3e-05	0.000174	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PLCB1—Alzheimer's disease	2.29e-05	0.000174	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—ENO1—Alzheimer's disease	2.29e-05	0.000173	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PTGS1—Alzheimer's disease	2.29e-05	0.000173	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	2.25e-05	0.00017	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CYP2D6—Alzheimer's disease	2.24e-05	0.00017	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PPARGC1A—Alzheimer's disease	2.22e-05	0.000169	CbGpPWpGaD
Norethindrone—ALB—Metabolism—ABCA1—Alzheimer's disease	2.22e-05	0.000168	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—HMOX1—Alzheimer's disease	2.21e-05	0.000168	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—CASP3—Alzheimer's disease	2.19e-05	0.000166	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—BCHE—Alzheimer's disease	2.18e-05	0.000165	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—BCHE—Alzheimer's disease	2.13e-05	0.000161	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PLCB1—Alzheimer's disease	2.06e-05	0.000156	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PPARG—Alzheimer's disease	2.04e-05	0.000155	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—LPL—Alzheimer's disease	2.02e-05	0.000153	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	2.02e-05	0.000153	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—MAPK8—Alzheimer's disease	2.01e-05	0.000153	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PLCB1—Alzheimer's disease	2.01e-05	0.000152	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—INS—Alzheimer's disease	2e-05	0.000152	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—ABCA1—Alzheimer's disease	1.99e-05	0.000151	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—ABCA1—Alzheimer's disease	1.95e-05	0.000148	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—VEGFA—Alzheimer's disease	1.94e-05	0.000147	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—TPI1—Alzheimer's disease	1.94e-05	0.000147	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CHAT—Alzheimer's disease	1.94e-05	0.000147	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PPARGC1A—Alzheimer's disease	1.91e-05	0.000145	CbGpPWpGaD
Norethindrone—ALB—Metabolism—HMOX1—Alzheimer's disease	1.91e-05	0.000144	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—MAOB—Alzheimer's disease	1.86e-05	0.000141	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—VEGFA—Alzheimer's disease	1.86e-05	0.000141	CbGpPWpGaD
Norethindrone—PGR—Gene Expression—AKT1—Alzheimer's disease	1.83e-05	0.000138	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—MTHFR—Alzheimer's disease	1.82e-05	0.000138	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	1.79e-05	0.000136	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—TGFB1—Alzheimer's disease	1.79e-05	0.000135	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—NOS3—Alzheimer's disease	1.76e-05	0.000133	CbGpPWpGaD
Norethindrone—ALB—Metabolism—LPL—Alzheimer's disease	1.74e-05	0.000132	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—A2M—Alzheimer's disease	1.73e-05	0.000131	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PPARGC1A—Alzheimer's disease	1.72e-05	0.00013	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—HMOX1—Alzheimer's disease	1.71e-05	0.00013	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—TGFB1—Alzheimer's disease	1.71e-05	0.000129	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—CALM1—Alzheimer's disease	1.7e-05	0.000129	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—APOE—Alzheimer's disease	1.7e-05	0.000129	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—CAV1—Alzheimer's disease	1.68e-05	0.000127	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PPARGC1A—Alzheimer's disease	1.68e-05	0.000127	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—HMOX1—Alzheimer's disease	1.67e-05	0.000127	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PTGS2—Alzheimer's disease	1.61e-05	0.000122	CbGpPWpGaD
Norethindrone—ALB—Metabolism—MTHFR—Alzheimer's disease	1.57e-05	0.000119	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—LPL—Alzheimer's disease	1.56e-05	0.000119	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—LPL—Alzheimer's disease	1.53e-05	0.000116	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ACHE—Alzheimer's disease	1.5e-05	0.000114	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	1.49e-05	0.000113	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PPARG—Alzheimer's disease	1.48e-05	0.000112	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—TP53—Alzheimer's disease	1.47e-05	0.000111	CbGpPWpGaD
Norethindrone—ALB—Metabolism—CALM1—Alzheimer's disease	1.47e-05	0.000111	CbGpPWpGaD
Norethindrone—ALB—Metabolism—APOE—Alzheimer's disease	1.46e-05	0.000111	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—INS—Alzheimer's disease	1.45e-05	0.00011	CbGpPWpGaD
Norethindrone—ALB—Metabolism—CAV1—Alzheimer's disease	1.45e-05	0.00011	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	1.41e-05	0.000107	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ENO1—Alzheimer's disease	1.41e-05	0.000107	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—MTHFR—Alzheimer's disease	1.41e-05	0.000107	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—TP53—Alzheimer's disease	1.41e-05	0.000107	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	1.38e-05	0.000105	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—MTHFR—Alzheimer's disease	1.37e-05	0.000104	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CALM1—Alzheimer's disease	1.32e-05	9.98e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—APOE—Alzheimer's disease	1.31e-05	9.94e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—BCHE—Alzheimer's disease	1.31e-05	9.94e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CAV1—Alzheimer's disease	1.3e-05	9.85e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—IL6—Alzheimer's disease	1.29e-05	9.75e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CALM1—Alzheimer's disease	1.28e-05	9.74e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—APOE—Alzheimer's disease	1.28e-05	9.7e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PPARG—Alzheimer's disease	1.27e-05	9.65e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—NOS3—Alzheimer's disease	1.27e-05	9.63e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CAV1—Alzheimer's disease	1.27e-05	9.61e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—INS—Alzheimer's disease	1.25e-05	9.46e-05	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—AKT1—Alzheimer's disease	1.24e-05	9.41e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	1.24e-05	9.38e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	1.2e-05	9.09e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—AKT1—Alzheimer's disease	1.19e-05	9e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PTGS2—Alzheimer's disease	1.16e-05	8.81e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PPARG—Alzheimer's disease	1.14e-05	8.66e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—INS—Alzheimer's disease	1.12e-05	8.49e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PPARG—Alzheimer's disease	1.11e-05	8.45e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—NOS3—Alzheimer's disease	1.09e-05	8.3e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—INS—Alzheimer's disease	1.09e-05	8.29e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	1.03e-05	7.83e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	1.03e-05	7.8e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PTGS2—Alzheimer's disease	1e-05	7.59e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—NOS3—Alzheimer's disease	9.83e-06	7.45e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—NOS3—Alzheimer's disease	9.59e-06	7.27e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—LPL—Alzheimer's disease	9.41e-06	7.13e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PTGS2—Alzheimer's disease	8.99e-06	6.81e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PTGS2—Alzheimer's disease	8.77e-06	6.65e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	8.47e-06	6.42e-05	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—AKT1—Alzheimer's disease	8.08e-06	6.13e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CALM1—Alzheimer's disease	7.91e-06	6e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—APOE—Alzheimer's disease	7.89e-06	5.98e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CAV1—Alzheimer's disease	7.81e-06	5.92e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PPARG—Alzheimer's disease	6.87e-06	5.21e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—INS—Alzheimer's disease	6.74e-06	5.11e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—NOS3—Alzheimer's disease	5.91e-06	4.48e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—AKT1—Alzheimer's disease	5.84e-06	4.43e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	5.4e-06	4.1e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—AKT1—Alzheimer's disease	5.03e-06	3.81e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—AKT1—Alzheimer's disease	4.52e-06	3.42e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—AKT1—Alzheimer's disease	4.41e-06	3.34e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—AKT1—Alzheimer's disease	2.72e-06	2.06e-05	CbGpPWpGaD
